A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Running, not enrolling

Conditions studied: Hepatocellular Cancer

In brief

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Key facts

Study ID

NCT02954094

Run by

Target PharmaSolutions, Inc.

People needed

10000

Starts

2016-12-01

Expected to finish

2027-02-01

Last updated by the study team

2026-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients, age ≥18 years
• Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

You may not qualify if…

• Inability to provide written informed consent

Where it is running

• University of Arkansas — Little Rock, Arkansas, United States
• University of Southern California/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• Stanford University — Palo Alto, California, United States
• California Liver Research Institute — Pasadena, California, United States
• University of California-Davis — Sacramento, California, United States
• University of California — San Francisco, California, United States
• Georgetown University — Washington D.C., District of Columbia, United States
• Gastro Florida — Clearwater, Florida, United States
• University of Florida Hepatology Research at CTRB — Gainesville, Florida, United States
• University of Florida Health Gastroenterology — Jacksonville, Florida, United States
• Schiff Center for Liver Diseases/University of Miami — Miami, Florida, United States
• Tampa General Medical Group — Tampa, Florida, United States
• Piedmont Atlanta Hospital — Atlanta, Georgia, United States
• Piedmont Cancer Institute — Atlanta, Georgia, United States
• Emory University Hospital — Atlanta, Georgia, United States
• Northwestern University Division of Gastroenterology and Hepatology — Chicago, Illinois, United States
• Rush University Medical Center — Chicago, Illinois, United States
• University of Chicago — Chicago, Illinois, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• Tulane University — New Orleans, Louisiana, United States
• Mercy Medical Center, GI Research — Baltimore, Maryland, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Banner University Medical Center — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.